echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Nature Immunology: a new discovery against autoimmune diseases

    Nature Immunology: a new discovery against autoimmune diseases

    • Last Update: 2020-01-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, researchers from Cincinnati Children's Hospital Medical Center and other scientific research institutions published an article entitled "T cells instruct myeloid cells to produce inflammatory-independent IL-1 β and cause autoimmunity" on Nature Immunology A new trigger T cell was found in mice to drive inflammation and cause multiple autoimmunity The molecular process of sexual diseases provides a theoretical basis for the treatment of multiple sclerosis, type 1 diabetes and inflammatory bowel disease Interleukin-1 β (IL-1 β) is the key factor of anti-bacterial immunity and autoimmune inflammation The production of IL-1 β requires innate immune receptor signal transduction and mature shear of inflammatory bodies It is not clear whether this mechanism is applicable to the production of IL-1 β in T cell driven autoimmune diseases The researchers found that IL-1 β produced an inflammatory body independent pathway, which was triggered by the homologous interaction between CD4 + T cells and mononuclear phagocytes (MPS) TNF (tumor necrosis factor) produced by activated CD4 + T cells binds to TNF receptor (TNFR) on MP, resulting in the synthesis of IL-1 β precursor The apoptotic signal transduction receptor Fas in MP is activated by Fas ligand (FasL) expressed by CD4 + T cells, resulting in caspase-8 dependent IL-1 β precursor shear Mature IL-1 β leads to systemic inflammation, while the absence of TNFR or Fas signal can protect mice from CD4 + T cell driven autoimmunity The TNFR – Fas – caspase-8 dependent pathway provides a mechanism for IL-1 β production and its role in CD4 + T cell driven autoimmune pathology  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.